We are live on
!
Find out more
KA
Kintegral Advisory Portfolio holdings
AUM
$1.06B
1-Year Est. Return
24.93%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$550M
AUM Growth
+$47.8M
(+9.5%)
Cap. Flow
-$677K
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
28.86%
Holding
269
New
1
Increased
2
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$991K |
| 2 |
Truist Financial
TFC
|
+$326K |
| 3 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$45K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.72M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$320K |
| 3 |
3M
MMM
|
+$560 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.68% |
| 2 | Healthcare | 14.72% |
| 3 | Financials | 13.9% |
| 4 | Communication Services | 10.73% |
| 5 | Consumer Staples | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.96T
| $41.9M | 7.62% |
265,588
| – | – |
|
2
Apple
AAPL
$4.76T
| $24.8M | 4.51% |
338,136
| – | – |
|
3
Alphabet (Google) Class A
GOOGL
$4.27T
| $15.2M | 2.77% |
227,260
| – | – |
|
4
Meta Platforms (Facebook)
META
$1.64T
| $13.6M | 2.47% |
66,092
| – | – |
|
|
5
Alphabet (Google) Class C
GOOG
$4.26T
| $13.1M | 2.37% |
195,340
| – | – |
|
6
Accenture
ACN
$87.7B
| $10.8M | 1.96% |
51,109
| – | – |
|
7
Procter & Gamble
PG
$343B
| $10.7M | 1.95% |
85,675
| – | – |
|
8
Ecolab
ECL
$74.5B
| $10.3M | 1.87% |
53,144
| – | – |
|
9
Intel
INTC
$518B
| $9.78M | 1.78% |
163,336
| – | – |
|
10
Merck
MRK
$309B
| $8.66M | 1.57% |
99,130
| – | – |
|
11
Cisco
CSCO
$442B
| $7.34M | 1.33% |
152,973
| – | – |
|
12
Walt Disney
DIS
$167B
| $6.64M | 1.21% |
45,635
| – | – |
|
|
13
3M
MMM
$89.7B
| $6.54M | 1.19% |
44,350
-4
| -0% | -$560 |
|
14
Salesforce
CRM
$140B
| $6.09M | 1.11% |
37,476
| – | – |
|
15
Nike
NKE
$64B
| $5.83M | 1.06% |
57,381
| – | – |
|
16
Blackrock
BLK
$163B
| $5.68M | 1.03% |
11,291
| – | – |
|
17
Oracle
ORCL
$359B
| $5.21M | 0.95% |
98,406
| – | – |
|
18
PepsiCo
PEP
$184B
| $5.17M | 0.94% |
37,544
| – | – |
|
19
Coca-Cola
KO
$351B
| $5.15M | 0.94% |
93,080
| – | – |
|
20
Amgen
AMGN
$196B
| $4.88M | 0.89% |
20,247
| – | – |
|
|
MRSH
21
Marsh
MRSH
$90.6B
| $4.86M | 0.88% |
43,653
| – | – |
|
22
American Express
AXP
$239B
| $4.86M | 0.88% |
39,014
| – | – |
|
23
NVIDIA
NVDA
$5.01T
| $4.85M | 0.88% |
824,360
| – | – |
|
24
Verizon
VZ
$179B
| $4.85M | 0.88% |
78,925
| – | – |
|
25
Texas Instruments
TXN
$265B
| $4.83M | 0.88% |
37,684
| – | – |
|
Similar funds
MWA
SFP
CA
MFS
ECM
NRG
HW
LAM
Kintegral Advisory's Q4 2019 Portfolio in Review
As of Q4 2019, Kintegral Advisory held 269 positions worth $550M, up 9.5% from $502M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 1.1%. Kintegral Advisory opened 1 new position and exited 2, leaving the 269-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Kintegral Advisory's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 17,299 shares worth $52K.
- Kintegral Advisory added most to Bristol-Myers Squibb in Q4 2019, an estimated $991K increase.
- Kintegral Advisory's biggest Q4 2019 reduction was 3M, cutting an estimated $560.
- Kintegral Advisory fully exited Celgene Corp in Q4 2019, selling an estimated $1.72M.
- Kintegral Advisory's ten largest holdings make up 29% of its $550M portfolio in Q4 2019.
- Kintegral Advisory opened 1 new position and closed 2 in Q4 2019.
- Kintegral Advisory's portfolio value rose 9.5% quarter-over-quarter to $550M.
Based on Kintegral Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.